Takeda grants 25,078 ADS RSUs to executive

Ibrahim Ramy Riad Ahmed reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ibrahim Ramy Riad Ahmed reported acquisition or exercise transactions in this Form 4 filing.

TAKEDA PHARMACEUTICAL CO LTD reported that President, PDT BU, Ramy Riad Ahmed received a grant of 25,078 American Depositary Share-based restricted stock units as equity compensation. The award was granted at no cash cost to him and increases his direct holdings to 109,865 American Depositary Shares.

The restricted stock units vest in three equal annual installments beginning on July 1, 2027, meaning the executive earns one-third of the shares each year over a three-year period, as long as the vesting conditions are met.

Insider Trade Summary

Grant/Award: 25,078 shares

Grant/Award 1 txn

Insider Ibrahim Ramy Riad Ahmed

Role President, PDT BU

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	25,078	$0.00	$0.00

Holdings After Transaction: American Depositary Shares — 109,865 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Key Figures

RSUs granted: 25,078 American Depositary Shares Holdings after transaction: 109,865 American Depositary Shares Grant price: $0.00 per share +1 more

4 metrics

RSUs granted 25,078 American Depositary Shares Grant of RSU award to President, PDT BU

Holdings after transaction 109,865 American Depositary Shares Direct ownership following RSU grant

Grant price $0.00 per share Equity compensation, no cash paid by executive

Vesting schedule 3 equal annual installments RSUs begin vesting July 1, 2027

Key Terms

restricted stock units (RSUs), American Depositary Shares, vest in three equal annual installments, contingent right

4 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

vest in three equal annual installments financial

"The RSUs vest in three equal annual installments beginning on July 1, 2027."

contingent right financial

"Each RSU represents a contingent right to receive one American Depositary Share."

FAQ

What insider transaction did TAK’s executive report on this Form 4?

TAKEDA PHARMACEUTICAL’s President, PDT BU, reported receiving 25,078 restricted stock units linked to American Depositary Shares. This equity award was granted at no cash cost and is a form of stock-based compensation, adding to his existing position in the company.

How many Takeda (TAK) shares does the executive hold after this RSU grant?

After the 25,078 restricted stock units were awarded, the executive’s direct holdings total 109,865 American Depositary Shares. This figure reflects his position following the grant, giving investors a sense of his ongoing equity exposure to TAKEDA PHARMACEUTICAL’s performance.

When do the new Takeda (TAK) restricted stock units vest?

The 25,078 restricted stock units vest in three equal annual installments starting on July 1, 2027. One-third of the award vests each year for three years, assuming continued satisfaction of the vesting conditions disclosed with the grant.

What exactly was granted to the Takeda (TAK) executive in this filing?

The executive received an award of restricted stock units, or RSUs, where each RSU represents a contingent right to receive one American Depositary Share. These RSUs provide potential future share delivery rather than immediate stock ownership at the time of the grant.

Was this Takeda (TAK) insider transaction an open-market stock purchase?

No, this was not an open-market stock purchase. The Form 4 shows a grant of 25,078 restricted stock units at a price of $0.00 per unit, indicating equity compensation rather than shares bought on the market by the executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ibrahim Ramy Riad Ahmed

(Last) (First) (Middle)

500 KENDALL STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, PDT BU

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		25,078	A	$0	109,865	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Kate Huleatt, by power of attorney, for Ramy R. Ibrahim	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)